Results 21 to 30 of about 8,348,024 (289)

Chronic graft-versus-host disease – the role of dermatological treatment [PDF]

, 2017
Introduction . The number of allogeneic haematopoietic stem cell transplantations is increasing year by year. The most common long-term complication is chronic graft-versus-host disease, with skin involvement noted in over 90% of cases. Objective . To
Joanna Gruber-Kopczyńska, Magdalena Żychowska, Małgorzata Tupikowska-Marzec, Joanna Maj   +3 more
core   +1 more source

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis

Haematologica, 2019
The use of antihuman T-lymphocyte immunoglobulin in the setting of transplantation from an HLA-matched related donor is still much debated. Acute and chronic graft-versus-host disease are the main causes of morbidity and mortality after allogeneic ...
Marie Robin, Sylvie Chevret, Linda Koster, Christine Wolschke, Ibrahim Yakoub-Agha, Jean Henri Bourhis, Patrice Chevallier, Jan J. Cornelissen, Péter Reményi, Johan Maertens, Xavier Poiré, Charles Craddock, Gérard Socié, Maija Itälä-Remes, Harry C. Schouten, Tony Marchand, Jakob Passweg, Didier Blaise, Gandhi Damaj, Zubeyde Nur Ozkurt, Tsila Zuckerman, Thomas Cluzeau, Hélène Labussière-Wallet, Jörg Cammenga, Donal McLornan, Yves Chalandon, Nicolaus Kröger   +26 more
doaj   +1 more source

PET assessment of acute gastrointestinal graft versus host disease

, 2023
Acute gastrointestinal graft versus host disease (GI-GVHD) is a common complication following allogeneic haematopoietic cell transplantation (HCT), and is characterised by severe morbidity, frequent treatment-refractoriness, and high mortality.
Glen A. Kennedy, Siok-Keen Tey, Henden, Andrea, Kennedy, Glen AA, Ashleigh P. Scott, Scott, Ashleigh PP, Andrea Henden, Tey, Siok-Keen   +7 more
core   +1 more source

SUPPLEMENTAL INFORMATION Acute graft-versus-host disease presenting as Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective cohort study

, 2022
Supplemental material for Manuscript: Acute graft-versus-host disease presenting as Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective cohort study (JAAD-D-22-00806R1)Supplemental Method and Material.
Hung, Y (via Mendeley Data)
core   +4 more sources

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant

Haematologica, 2017
Severe graft-versus-host disease is a major barrier for non-T-cell-depleted haploidentical stem cell transplantation. There is no consensus on the optimal graft-versus-host disease prophylaxis.
Annalisa Ruggeri, Yuqian Sun, Myriam Labopin, Andrea Bacigalupo, Francesca Lorentino, William Arcese, Stella Santarone, Zafer Gülbas, Didier Blaise, Giuseppe Messina, Ardeshi Ghavamzadeh, Florent Malard, Benedetto Bruno, Jose Luis Diez-Martin, Yener Koc, Fabio Ciceri, Mohamad Mohty, Arnon Nagler   +17 more
doaj   +1 more source

Pathophysiology of acute graft‐versus‐host disease [PDF]

Hematological Oncology, 2003
AbstractGraft‐versus‐host disease (GVHD) has been the primary limitation to the wider application of allogeneic bone marrow transplantation (BMT). The pathophysiology of acute GVHD is complex and can be conceptualized to be a three‐step process based on murine studies.
openaire   +3 more sources

Human Graft Versus Host Disease [PDF]

, 1980
Human graft versus host disease is composed of 2 distinct clinical entities, acute graft versus host disease and chronic graft versus host disease, which have different pathogenesis.
Robertson Parkman, Joel Rappeport, Parkman, Robertson, Rosen, Fred, Fred Rosen, Rappeport, Joel   +5 more
core   +1 more source

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups

Haematologica, 2016
Graft-versus-host disease-free relapse-free survival, which is defined as the absence of grade III–IV acute graft-versus-host disease, systemically treated chronic graft-versus-host disease, relapse, and death, is a novel, meaningful composite end point ...
Yoshihiro Inamoto, Fumihiko Kimura, Junya Kanda, Junichi Sugita, Kazuhiro Ikegame, Hideki Nakasone, Yasuhito Nannya, Naoyuki Uchida, Takahiro Fukuda, Kosuke Yoshioka, Yukiyasu Ozawa, Ichiro Kawano, Yoshiko Atsuta, Koji Kato, Tatsuo Ichinohe, Masami Inoue, Takanori Teshima   +16 more
doaj   +1 more source

Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids

Haematologica, 2011
Background Advances in acute graft-versus-host disease therapy are needed.Design and Methods We examined the efficacy of sirolimus as primary therapy for acute graft-versus-host disease in 32 patients.Results Acute graft-versus-host disease involved the ...
Joseph Pidala, Marcie Tomblyn, Taiga Nishihori, Teresa Field, Ernesto Ayala, Janelle Perkins, Hugo Fernandez, Fred Locke, Lia Perez, Jose Leonel Ochoa, Melissa Alsina, Claudio Anasetti   +11 more
doaj   +1 more source

Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation

Haematologica, 2021
HLA-DPB1 mismatches between donor and recipient are commonly seen in allogeneic hematopoietic stem cell transplantation from an unrelated donor. HLA-DPB1 mismatch, conventionally determined by the similarity of the T-cell epitope (TCE), is associated ...
Jun Zou, Piyanuch Kongtim, Betül Oran, Vasilis Kosmoliaptsis, Yudith Carmazzi, Junsheng Ma, Liang Li, Gabriela Rondon, Samer Srour, Hannah C. Copley, David Partlow, Stefan O. Ciurea, Uri Greenbaum, Qing Ma, Elizabeth J. Shpall, Richard E. Champlin, Kai Cao   +16 more
doaj   +1 more source